Dactinomycin and neutropenia Patient Reports February 12, 2012

Dactinomycin Side Effects Report #5281236-7
Dactinomycin side effect was reported by a Physician from JAPAN on Mar 13, 2007. Female patient, 35 years of age, was diagnosed with benign hydatidiform mole and was treated with Dactinomycin. After drug was administered, patient experienced the following side effects: blister, erythema multiforme, hepatic function abnormal, nausea , neutropenia. Dactinomycin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, KYTRIL, MEYLON. Patient was hospitalized. Patient recovered.

Dactinomycin Side Effects Report #5297333-6
Dactinomycin side effect was reported by a Physician from JAPAN on Mar 26, 2007. Female patient, 35 years of age, was diagnosed with benign hydatidiform mole and was treated with Dactinomycin. After drug was administered, patient experienced the following side effects: blister, erythema multiforme, haemoglobin decreased, hepatic function abnormal, nausea , neutropenia, white blood cell count decreased. Dactinomycin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DECADRON, METHOTREXATE. Patient was hospitalized. Patient recovered.

Dactinomycin Side Effects Report #5309390-9
Dactinomycin side effect was reported by a Physician from JAPAN on Apr 11, 2007. Female patient, 35 years of age, was diagnosed with benign hydatidiform mole, antiemetic supportive care and was treated with Dactinomycin. After drug was administered, patient experienced the following side effects: blister, erythema multiforme, haemoglobin decreased, hepatic function abnormal, nausea , neutropenia, pruritus, toxic skin eruption. Dactinomycin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DECADRON. Patient was hospitalized. Patient recovered.

Dactinomycin Side Effects Report #5607390-2
Dactinomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 28, 2008. Female patient, weighting 121.3 lb, was treated with Dactinomycin. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, haemolytic uraemic syndrome, hyperbilirubinaemia, ileus, liver disorder, necrotising fasciitis, neutropenia, pyrexia. Dactinomycin dosage: .045 MG. During the same period patient was treated with VINCRISTINE. Patient was hospitalized. Patient recovered.


Dactinomycin Side Effects Report #5609084-6
Dactinomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2008. Female patient, weighting 114.0 lb, was treated with Dactinomycin. After drug was administered, patient experienced the following side effects: coagulopathy, dehydration, hyperbilirubinaemia, ileus, necrotising fasciitis, neutropenia, oliguria, pyrexia, rash . Dactinomycin dosage: .045 ML. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Dactinomycin Side Effects Report #5616343-X
Dactinomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2008. Female patient, weighting 114.0 lb, was treated with Dactinomycin. After drug was administered, patient experienced the following side effects: coagulation test abnormal, dehydration, gas gangrene, ileus, necrotising fasciitis, neutropenia, oliguria, pneumatosis, pyrexia. Dactinomycin dosage: 0.45 MG 0.045 MG/KG/DAY X 1 DOSE. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Dactinomycin Side Effects Report #5631869-0
Dactinomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2008. Female patient, weighting 114.0 lb, was treated with Dactinomycin. After drug was administered, patient experienced the following side effects: coagulopathy, dehydration, gas gangrene, hyperbilirubinaemia, ileus, necrotising fasciitis, neutropenia, oliguria, pneumatosis. Dactinomycin dosage: 2.3 MG 0.045 MG/KG/DAY X 1 DOSE. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.